EANM guidelines on the use of [<sup>18</sup>F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39207486.
- Also identified by DOI 10.1007/s00259-024-06858-9 and PMC identifier 11599630.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
We provide updated guidance and standards for the indication, acquisition, and interpretation of [<sup>18</sup>F]FDG PET/CT for plasma cell disorders. Procedures and characteristics are reported and different scenarios for the clinical use of [<sup>18</sup>F]FDG PET/CT are discussed. This document provides clinicians and technicians with the best available evidence to support the implementation of [<sup>18</sup>F]FDG PET/CT imaging in routine practice and future research.
Medical subject headings
- Fluorodeoxyglucose F18
- Positron Emission Tomography Computed Tomography